戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 229564作成日:2026年10月25日

Acetate → Bupropion

https://huagongshe.com/reaction/229564

反応式

関与物質

役割名称HCID仕込み量
反応物AcetateHCID 175—
反応物PhosphateHCID 1061—
反応物Bupropion HydrochlorideHCID 62884—
反応物Bupropion HydrobromideHCID 11984562—
生成物BupropionHCID 444—

反応手順

The dissolution of bupropion HBr formulations according to the invention were assessed in three USP-3 media, i.e., SGF pH 1.2, Acetate Buffer pH 4.5 and Phosphate Buffer pH 6.8 over a period of 16 hours. These results are contained in FIG. 66. Particularly Bupropion HBr XL 348 mg tablets (final), Lot # Bup-HBr-XL-012-5; Wellbutrin XL 300 mg tablets (final), Lot # 05A116; Bupropion HBr XL 348 mg tablets ECl Lot # Bup-HBr-XL-012-5 (EC 32 mg wg) and Wellbutrin XL 300 mg tablets (EC10-Lot # 05D047 were assessed in SGF media pH 1.2 for 2 hours, Acetate Buffer pH 4.5 for 2 hours, and Phosphate Buffer SIF pH 6.8 for a total of 10 hours. The results are contained in the FIG. 66-68.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US07563823B2
出典データセットuspto-grants-2009_07
ORD IDord-40e1bbce3083436c940deac123c8d01f
出典メモuspto-grants-2009_07